How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Laboratory Forceps Market
- By Material: Stainless Steel, Titanium, Plastic, Aluminum, Carbon Steel
- By Tip Type: Serrated Tips, Smooth Tips, Curved Tips, Straight Tips, Fine Tips
- By Application: Medical and Surgical, Laboratory Research, Dental Procedures, Veterinary Use, Electronics Handling
- By Length: Short (up to 100 mm), Medium (101-150 mm), Long (above 150 mm)
- By Sterilization Compatibility: Autoclave Compatible, Chemical Sterilization Compatible, Disposable/Single-use
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Stainless Steel leads By Material at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 298 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.180 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.188 →
Full report · locked preview
Everything inside the Laboratory Forceps Market report
A complete, evidence-based study - 12 chapters and 125 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Material 5
Tip Type 5
Application 5
Length 3
Sterilization Compatibility 3
Companies profiled
Thermo Fisher Scientific
Medline Industries
VWR International (part of Avantor)
BD (Becton
Dickinson and Company)
Integra LifeSciences
Miltex (part of Integra LifeSciences)
Fine Science Tools
Dumont
Roboz Surgical Instrument Co.
F.S. Smith & Nephew
Aesculap (B. Braun)
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Medline Industries
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →VWR International (part of Avantor)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →BD (Becton
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Dickinson and Company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Integra LifeSciences
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Miltex (part of Integra LifeSciences)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Fine Science Tools
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Dumont
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Roboz Surgical Instrument Co.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →F.S. Smith & Nephew
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Aesculap (B. Braun)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Karl Storz
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Surgical Specialties Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Hu-Friedy
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Ningbo David Medical Device Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,339M by 2033 · 9.7% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Stainless Steel44.6
- Titanium9.7
- Plastic16.0
- Aluminum18.8
- Carbon Steel10.8
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$684.0M → $1,449M · 9.8%
Europe$476.7M → $1,091M · 10.9%
Asia Pacific$435.3M → $904.9M · 9.6%
Latin America$269.4M → $542.1M · 9.1%
Middle East and Africa$207.3M → $418.7M · 9.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.632026
9.632027
9.642028
9.652029
9.682030
9.692031
9.702032
9.712033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Thermo Fisher Scientific22.9
- Medline Industries15.1
- VWR International (part of Avantor)8.6
- BD (Becton11.6
- Dickinson and Company)3.7
- Integra LifeSciences10.1
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Material15.9%
Tip Type19.5%
Application30.5%
Length14.8%
Sterilization Compatibility19.3%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.9
- Europe24.8
- Asia Pacific20.5
- Latin America12.3
- Middle East and Africa9.5
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | 85 | 75 | 93 | 82 | 76 | 94 | 84 |
| Medline Industries | 77 | 68 | 84 | 72 | 84 | 68 | 76 |
| VWR International (part of Avantor) | 67 | 79 | 69 | 63 | 74 | 69 | 70 |
| BD (Becton | 63 | 69 | 79 | 78 | 64 | 59 | 69 |
| Dickinson and Company) | 57 | 70 | 59 | 76 | 71 | 55 | 65 |
| Integra LifeSciences | 68 | 53 | 52 | 51 | 65 | 56 | 58 |
| Miltex (part of Integra LifeSciences) | 43 | 60 | 52 | 54 | 48 | 41 | 50 |
| Fine Science Tools | 59 | 43 | 39 | 55 | 44 | 36 | 46 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Thermo Fisher Scientific
- Medline Industries
- VWR International (part of Avantor)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | ✓ | ◐ | ◐ | ✓ | ◐ | ◐ |
| Medline Industries | ◐ | ◐ | ◐ | ◐ | ✓ | ◐ |
| VWR International (part of Avantor) | ◐ | ◐ | ◐ | ✓ | ◐ | ✓ |
| BD (Becton | ◐ | ◐ | ◐ | ✓ | ◐ | ◐ |
| Dickinson and Company) | − | ◐ | ◐ | ◐ | ◐ | − |
| Integra LifeSciences | ✓ | − | − | ◐ | ◐ | ◐ |
| Miltex (part of Integra LifeSciences) | − | ◐ | − | − | ◐ | − |
| Fine Science Tools | − | − | − | − | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Thermo Fisher Scientific84
2Medline Industries76
3VWR International (part of Avantor)70
4BD (Becton69
5Dickinson and Company)65
6Integra LifeSciences58
7Miltex (part of Integra LifeSciences)50
8Fine Science Tools46
Competitive tiers
§8.4 · p.172 →Leader1
Set the pace on share, breadth and innovation.
Thermo Fisher Scientific
Challenger3
Strong scale, closing on the leaders.
Medline IndustriesVWR International (part of Avantor)BD (Becton
Contender2
Focused players with pockets of strength.
Dickinson and Company)Integra LifeSciences
Niche2
Specialists in a single segment or region.
Miltex (part of Integra LifeSciences)Fine Science Tools
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Material in North America, then scale across Laboratory Forceps Market — a $74M beachhead inside a $1.08B market.
Beachhead (SOM)$74Mobtainable near-term
Serviceable (SAM)$416Mreachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Stainless Steel
Best fit — highest urgency & budget in Material.
Economic buyer77 fit
Titanium
Strong fit — clear ROI and a fast path to value.
End user66 fit
Plastic
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Material in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Tip Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales47%
Partner / channel26%
Digital / self-serve19%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Material leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Laboratory Forceps Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified23%
Evaluation12%
Closed-won7%
$17.1KCAC
$70KLTV
4.1:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Laboratory Forceps Market is a durable-growth opportunity — $8.98B by 2033, compounding at 6.9%.
TAM · 2025$5.27Btoday
TAM · 2033$8.98Bforecast
CAGR6.9%2027–2033
Cumulative$62.8Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$8.98BTotal addressable market
SAM$3.22BServiceable available market
SOM$670MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.9% CAGR
Demand compounds through 2033, outpacing GDP across Material.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Material moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$8.98BLarge & growingTAM by 2033 at 6.9% CAGR
$3.22BServiceable nowreachable with today’s model
$670MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$7.00BBear4.5% CAGR
$8.98BBase6.9% CAGR
$11.5BBull9.1% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Tip Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Laboratory Forceps Market — a $2.72B market by 2033. Plan: grow share from 8.5% to 17.6%.
Market size · 2033$2.72Btotal addressable
Market CAGR8.6%2027–2033
Target share17.6%from 8.5% today
Revenue ambition$479Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.5% | 17.6% | On track |
| Revenue | $231M | $479M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 34.9% | 45.6% | At risk |
| Customer retention | 84.6% | 92.4% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Material
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Tip Type capability
A defensible second engine — invest in Tip Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Material share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Tip Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $50M capacity & capability investment
- Greenlight bolt-on M&A in Tip Type
- Authorise North America expansion plan
- Fund R&D program for Material leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossOn track
- Input-cost & supply riskAt risk
- Regulatory / policy changeAhead
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Laboratory Forceps Market conversation — a $2.32B market you can size, segment and defend in minutes.
Market size · 2033$2.32Btotal opportunity
Growth9.9%CAGR to 2033
Addressable buyers1,689+accounts in scope
Typical ROI6×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Material
Goal Grow share in Material
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6×return on cost, year one
< 4 mopayback period
$100K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Thermo Fisher ScientificMedline IndustriesVWR International (part of Avantor)BD (BectonDickinson and Company)Integra LifeSciencesMiltex (part of Integra LifeSciences)Fine Science Tools+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Laboratory Forceps Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Laboratory Forceps Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Real-time PCR (QPCR) Instrument & Reagent Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportICD Devices Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportEndoscope Tracking Systems Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View report5G Infrastructure for Medical Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportNeurosurgery Software Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportIcatibant Acetate API Market
Market size, share, segmentation and regional forecast.
$938M market · 2025 base year
View reportICA (Islet Cell Antibody) ELISA (Enzyme immunoassay) Assay Kit Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportICAD (Intracranial Atherosclerotic Disease) Pathology Treatment Market
Market size, share, segmentation and regional forecast.
$769M market · 2025 base year
View reportCbd-Enhanced Probiotic Supplements Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportIbutilide Fumarate Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportIbuprofen Suspension Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportIbuprofen Soft Capsules Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.